Shingles Vaccine Linked to Lower Dementia Risk in Nursing Home Patients
A 24% reduction in dementia risk has been observed among older adults who received the recombinant zoster vaccine within a year of entering a skilled nursing facility. The findings, published in the Annals of Internal Medicine, emerge from an analysis of over 500,000 patient records across the United States.

Researchers from Brown University and the University of Delaware utilized a target trial emulation to evaluate the long-term outcomes of patients aged 66 and older. By cross-referencing Medicare claims with longitudinal electronic health records from PointClickCare Life Sciences, the team tracked clinical histories for individuals residing in long-term care settings. The resulting data suggests that vaccination acts as a significant factor in cognitive health preservation, though the study authors note that randomized trials are necessary to confirm a direct causal link.
This research highlights a persistent gap in medical data, as older adults in nursing facilities are frequently excluded from traditional clinical trials. Kaley Hayes, lead author and assistant professor at Brown University, noted that the integration of real-world nursing home data provided a clearer picture of vaccination history and clinical outcomes in this vulnerable demographic. Despite the potential benefits, the study also points to low vaccination uptake rates within these facilities, indicating a missed opportunity for preventative care for aging populations.
Comments (0)
No comments yet. Be the first!